{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:11:34Z","timestamp":1780405894264,"version":"3.54.1"},"reference-count":137,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"vor","delay-in-days":167,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL095524"],"award-info":[{"award-number":["HL095524"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL141810"],"award-info":[{"award-number":["HL141810"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"HHS | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG049665"],"award-info":[{"award-number":["AG049665"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001790","name":"Ara Parseghian Medical Research Foundation","doi-asserted-by":"publisher","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}],"id":[{"id":"10.13039\/100001790","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Support Of Accelerated Research for Niemann-Pick Type C Disease","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1074\/jbc.ra119.010524","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T20:55:23Z","timestamp":1588280123000},"page":"8017-8035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid"],"prefix":"10.1016","volume":"295","author":[{"given":"Kanagaraj","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Hutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0899-8381","authenticated-orcid":false,"given":"William E.","family":"Balch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.010524_bib1","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.celrep.2018.07.059","article-title":"Bridging genomics to phenomics at atomic resolution through variation spatial profiling","volume":"24","author":"Wang","year":"2018","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.RA119.010524_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/17460441.2019.1588882","article-title":"Animal models for Niemann-Pick type C: implications for drug discovery & development","volume":"14","author":"Fog","year":"2019","journal-title":"Expert Opin. Drug Discov"},{"key":"10.1074\/jbc.RA119.010524_bib3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3389\/fphys.2017.00982","article-title":"Lysosomal and mitochondrial liaisons in Niemann-Pick disease","volume":"8","author":"Torres","year":"2017","journal-title":"Front. Physiol"},{"key":"10.1074\/jbc.RA119.010524_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainres.2016.03.007","article-title":"Modeling Niemann-Pick type C1 using human embryonic and induced pluripotent stem cells","volume":"1656","author":"Ordo\u00f1ez","year":"2017","journal-title":"Brain Res"},{"key":"10.1074\/jbc.RA119.010524_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann-Pick disease type C","volume":"38","author":"Vanier","year":"2015","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.1074\/jbc.RA119.010524_bib6","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.celrep.2019.04.099","article-title":"Niemann-Pick type C disease reveals a link between lysosomal cholesterol and PtdIns(4,5)P2 that regulates neuronal excitability","volume":"27","author":"Vivas","year":"2019","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.RA119.010524_bib7","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/hmg\/ddy117","article-title":"High-content screen for modifiers of Niemann-Pick type C disease in patient cells","volume":"27","author":"Pugach","year":"2018","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA119.010524_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tcm.2003.12.003","article-title":"The Niemann-Pick disease genes: regulators of cellular cholesterol homeostasis","volume":"14","author":"Ory","year":"2004","journal-title":"Trends Cardiovasc. Med"},{"key":"10.1074\/jbc.RA119.010524_bib9","doi-asserted-by":"crossref","first-page":"46414","DOI":"10.1074\/jbc.M108099200","article-title":"Cholesterol overload promotes morphogenesis of a Niemann-Pick C (NPC)-like compartment independent of inhibition of NPC1 or HE1\/NPC2 function","volume":"276","author":"Frolov","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib10","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1073\/pnas.081070898","article-title":"Cessation of rapid late endosomal tubulovesicular trafficking in Niemann-Pick type C1 disease","volume":"98","author":"Zhang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010524_bib11","doi-asserted-by":"crossref","first-page":"21604","DOI":"10.1074\/jbc.271.35.21604","article-title":"Intracellular trafficking of cholesterol monitored with a cyclodextrin","volume":"271","author":"Neufeld","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/tra.12046","article-title":"The cytosolic adaptor AP-1A is essential for the trafficking and function of Niemann-Pick type C proteins","volume":"14","author":"Poirier","year":"2013","journal-title":"Traffic"},{"key":"10.1074\/jbc.RA119.010524_bib13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cell.2009.03.049","article-title":"Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol","volume":"137","author":"Kwon","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.RA119.010524_bib14","doi-asserted-by":"crossref","first-page":"18932","DOI":"10.1073\/pnas.1110439108","article-title":"Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding","volume":"108","author":"Deffieu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010524_bib15","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1021\/bi4005478","article-title":"Computational studies of the cholesterol transport between NPC2 and the N-terminal domain of NPC1 (NPC1(NTD))","volume":"52","author":"Estiu","year":"2013","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.010524_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrg.2017.89","article-title":"Prioritizing diversity in human genomics research","volume":"19","author":"Hindorff","year":"2018","journal-title":"Nat. Rev. Genet"},{"key":"10.1074\/jbc.RA119.010524_bib17","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1038\/s41467-019-12969-x","article-title":"Quantitating the epigenetic transformation contributing to cholesterol homeostasis using Gaussian process","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA119.010524_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1194\/jlr.M072140","article-title":"Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells","volume":"58","author":"Pipalia","year":"2017","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA119.010524_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/hmg\/ddp552","article-title":"Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration","volume":"19","author":"Elrick","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA119.010524_bib20","doi-asserted-by":"crossref","first-page":"e0178179","DOI":"10.1371\/journal.pone.0178179","article-title":"Quantitative magnetic resonance imaging of brain atrophy in a mouse model of Niemann-Pick type C disease","volume":"12","author":"Totenhagen","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010524_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jmri.22837","article-title":"In vivo assessment of neurodegeneration in Niemann-Pick type C mice by quantitative T2 mapping and diffusion tensor imaging","volume":"35","author":"Totenhagen","year":"2012","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1074\/jbc.RA119.010524_bib22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/jmri.23902","article-title":"1H magnetic resonance spectroscopy of neurodegeneration in a mouse model of Niemann-Pick type C1 disease","volume":"37","author":"Totenhagen","year":"2013","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1074\/jbc.RA119.010524_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymgme.2011.02.013","article-title":"In vivo quantification of brain injury in adult Niemann-Pick disease type C","volume":"103","author":"Zaaraoui","year":"2011","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.RA119.010524_bib24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/302626","article-title":"Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype","volume":"65","author":"Millat","year":"1999","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.RA119.010524_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10255","article-title":"Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1","volume":"22","author":"Park","year":"2003","journal-title":"Hum. Mutat"},{"key":"10.1074\/jbc.RA119.010524_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","article-title":"Niemann-Pick disease type C","volume":"64","author":"Vanier","year":"2003","journal-title":"Clin. Genet"},{"key":"10.1074\/jbc.RA119.010524_bib27","first-page":"81","article-title":"Cell-autonomous death of cerebellar purkinje neurons with autophagy in Niemann-Pick type C disease","volume":"1","author":"Ko","year":"2005","journal-title":"PLoS Genet"},{"key":"10.1074\/jbc.RA119.010524_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1750-1172-8-166","article-title":"Niemann-Pick disease type C symptomatology: an expert-based clinical description","volume":"8","author":"Mengel","year":"2013","journal-title":"Orphanet. J. Rare Dis"},{"key":"10.1074\/jbc.RA119.010524_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/humu.20636","article-title":"NPC-db, a Niemann-Pick type C disease gene variation database","volume":"29","author":"Runz","year":"2008","journal-title":"Hum. Mutat"},{"key":"10.1074\/jbc.RA119.010524_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbalip.2004.08.006","article-title":"The NPC1 protein: structure implies function","volume":"1685","author":"Scott","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA119.010524_bib31","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/320606","article-title":"Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop","volume":"68","author":"Millat","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.RA119.010524_bib32","doi-asserted-by":"crossref","first-page":"e82879","DOI":"10.1371\/journal.pone.0082879","article-title":"Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders","volume":"8","author":"Zech","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010524_bib33","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1074\/jbc.M708735200","article-title":"Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding","volume":"283","author":"Gelsthorpe","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ebiom.2018.11.037","article-title":"The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase","volume":"38","author":"Fog","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1074\/jbc.RA119.010524_bib35","doi-asserted-by":"crossref","first-page":"355ra118","DOI":"10.1126\/scitranslmed.aad9823","article-title":"Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses","volume":"8","author":"Kirkegaard","year":"2016","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/jbc.RA119.010524_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12192-016-0708-2","article-title":"Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol","volume":"21","author":"Deane","year":"2016","journal-title":"Cell Stress Chaperones"},{"key":"10.1074\/jbc.RA119.010524_bib37","doi-asserted-by":"crossref","first-page":"e1236","DOI":"10.1038\/cddis.2014.214","article-title":"The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa","volume":"5","author":"Parfitt","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1074\/jbc.RA119.010524_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci"},{"key":"10.1074\/jbc.RA119.010524_bib39","doi-asserted-by":"crossref","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010524_bib40","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010524_bib41","doi-asserted-by":"crossref","first-page":"276ra226","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/jbc.RA119.010524_bib42","doi-asserted-by":"crossref","first-page":"33716","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","article-title":"Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor","volume":"17","author":"Bowers","year":"2010","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.RA119.010524_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1097-2765(00)80452-9","article-title":"HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF","volume":"5","author":"Lau","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA119.010524_bib45","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.010524_bib46","doi-asserted-by":"crossref","first-page":"371832","DOI":"10.1155\/2011\/371832","article-title":"Physical and functional HAT\/HDAC interplay regulates protein acetylation balance","volume":"2011","author":"Peserico","year":"2011","journal-title":"J. Biomed. Biotechnol"},{"key":"10.1074\/jbc.RA119.010524_bib47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/jbc.RA119.010524_bib48","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40265-015-0388-8","article-title":"Panobinostat: first global approval","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"key":"10.1074\/jbc.RA119.010524_bib49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ja.2011.35","article-title":"Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma","volume":"64","author":"VanderMolen","year":"2011","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1074\/jbc.RA119.010524_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2008.01.019","article-title":"The Sirtuin family: therapeutic targets to treat diseases of aging","volume":"12","author":"Milne","year":"2008","journal-title":"Curr. Opin. Chem. Biol"},{"key":"10.1074\/jbc.RA119.010524_bib51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrm2938","article-title":"Heat shock factors: integrators of cell stress, development and lifespan","volume":"11","author":"Akerfelt","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.RA119.010524_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molcel.2006.12.008","article-title":"An acetylation site in the middle domain of Hsp90 regulates chaperone function","volume":"25","author":"Scroggins","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA119.010524_bib53","doi-asserted-by":"crossref","first-page":"E3661","DOI":"10.3390\/ijms19113661","article-title":"Hsp90 Stabilizes SIRT1 orthologs in mammalian cells and C. elegans","volume":"19","author":"Nguyen","year":"2018","journal-title":"Int. J. Mol. Sci"},{"key":"10.1074\/jbc.RA119.010524_bib54","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1523\/JNEUROSCI.3039-13.2014","article-title":"HSF1 protects neurons through a novel trimerization- and HSP-independent mechanism","volume":"34","author":"Verma","year":"2014","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA119.010524_bib55","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1021\/acschembio.9b00134","article-title":"Deconvoluting stress-responsive proteostasis signaling pathways for pharmacologic activation using targeted RNA sequencing","volume":"14","author":"Grandjean","year":"2019","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/jbc.RA119.010524_bib56","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.tcb.2017.08.002","article-title":"Rethinking HSF1 in stress, development, and organismal health","volume":"27","author":"Li","year":"2017","journal-title":"Trends Cell Biol"},{"key":"10.1074\/jbc.RA119.010524_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/B978-0-12-394387-3.00007-0","article-title":"HDAC inhibitors and chaperone function","volume":"116","author":"Rao","year":"2012","journal-title":"Adv. Cancer Res"},{"key":"10.1074\/jbc.RA119.010524_bib58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front. Oncol"},{"key":"10.1074\/jbc.RA119.010524_bib59","doi-asserted-by":"crossref","first-page":"23842","DOI":"10.1074\/jbc.M111.227645","article-title":"An \u201cexacerbate-reverse\u201d strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease","volume":"286","author":"Munkacsi","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib60","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1073\/pnas.1014890108","article-title":"Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts","volume":"108","author":"Pipalia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010524_bib61","doi-asserted-by":"crossref","first-page":"326ra323","DOI":"10.1126\/scitranslmed.aad9407","article-title":"Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model","volume":"8","author":"Alam","year":"2016","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/jbc.RA119.010524_bib62","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.bbalip.2019.04.011","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease","volume":"1864","author":"Davidson","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"10.1074\/jbc.RA119.010524_bib63","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2119\/molmed.2011.00021","article-title":"Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus","volume":"17","author":"Christensen","year":"2011","journal-title":"Mol. Med"},{"key":"10.1074\/jbc.RA119.010524_bib64","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.010524_bib65","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.leukres.2010.04.001","article-title":"Combined proteasome and histone deacetylase inhibition: a promising synergy for patients with relapsed\/refractory multiple myeloma","volume":"34","author":"Jagannath","year":"2010","journal-title":"Leuk. Res"},{"key":"10.1074\/jbc.RA119.010524_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/icb.2011.94","article-title":"Histone deacetylase inhibitors in the generation of the anti-tumour immune response","volume":"90","author":"Leggatt","year":"2012","journal-title":"Immunol. Cell Biol"},{"key":"10.1074\/jbc.RA119.010524_bib67","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/13543784.2010.510514","article-title":"The clinical development of histone deacetylase inhibitors as targeted anticancer drugs","volume":"19","author":"Marks","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1074\/jbc.RA119.010524_bib68","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrrheum.2011.162","article-title":"Rheumatoid arthritis: HDAC and HDACi: pathogenetic and mechanistic insights","volume":"7","author":"Buckland","year":"2011","journal-title":"Nat. Rev. Rheumatol"},{"key":"10.1074\/jbc.RA119.010524_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4939-7163-3_18","article-title":"Measuring the effect of histone deacetylase inhibitors (HDACi) on the secretion and activity of \u03b1-1 antitrypsin","volume":"1639","author":"Wang","year":"2017","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/jbc.RA119.010524_bib70","doi-asserted-by":"crossref","first-page":"e1001998","DOI":"10.1371\/journal.pbio.1001998","article-title":"Modulation of the maladaptive stress response to manage diseases of protein folding","volume":"12","author":"Roth","year":"2014","journal-title":"PLos Biol"},{"key":"10.1074\/jbc.RA119.010524_bib71","doi-asserted-by":"crossref","first-page":"38265","DOI":"10.1074\/jbc.M112.404707","article-title":"Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of \u03b11-antitrypsin deficiency","volume":"287","author":"Bouchecareilh","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/156652412801318782","article-title":"Proteostasis, an emerging therapeutic paradigm for managing inflammatory airway stress disease","volume":"12","author":"Bouchecareilh","year":"2012","journal-title":"Curr. Mol. Med"},{"key":"10.1074\/jbc.RA119.010524_bib73","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/epi-2017-0027","article-title":"Targeting transcription factor lysine acetylation in inflammatory airway diseases","volume":"9","author":"van den Bosch","year":"2017","journal-title":"Epigenomics"},{"key":"10.1074\/jbc.RA119.010524_bib74","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pharmthera.2013.10.008","article-title":"Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis","volume":"141","author":"Royce","year":"2014","journal-title":"Pharmacol. Ther"},{"key":"10.1074\/jbc.RA119.010524_bib75","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/10898520-000000000-00000","article-title":"Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches","volume":"70","author":"Marwick","year":"2010","journal-title":"Drugs"},{"key":"10.1074\/jbc.RA119.010524_bib76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1517\/14728222.11.6.745","article-title":"Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy","volume":"11","author":"Marwick","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/jbc.RA119.010524_bib77","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/156802609788085250","article-title":"Histone deacetylase inhibitors in inflammatory disease","volume":"9","author":"Halili","year":"2009","journal-title":"Curr. Top. Med. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib78","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1165\/rcmb.2010-0276OC","article-title":"Trichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models","volume":"46","author":"Banerjee","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"10.1074\/jbc.RA119.010524_bib79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1513\/pats.201008-055MS","article-title":"Proteostasis: a new therapeutic paradigm for pulmonary disease","volume":"8","author":"Bouchecareilh","year":"2011","journal-title":"Proc. Am. Thorac. Soc"},{"key":"10.1074\/jbc.RA119.010524_bib80","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/hmg\/ddz026","article-title":"HDAC inhibitors rescue multiple disease-causing CFTR variants","volume":"28","author":"Angl\u00e8s","year":"2019","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA119.010524_bib81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nchembio.275","article-title":"Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis","volume":"6","author":"Hutt","year":"2010","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.RA119.010524_bib82","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/ml200136e","article-title":"Potential agents for treating cystic fibrosis: cyclic tetrapeptides that restore trafficking and activity of \u0394F508-CFTR","volume":"2","author":"Hutt","year":"2011","journal-title":"ACS Med. Chem. Lett"},{"key":"10.1074\/jbc.RA119.010524_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol. Rev"},{"key":"10.1074\/jbc.RA119.010524_bib84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40266-018-00636-7","article-title":"Pharmacological management of dementia with Lewy bodies","volume":"36","author":"Hershey","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1074\/jbc.RA119.010524_bib85","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.phrs.2018.04.014","article-title":"Epigenetic modulation by small molecule compounds for neurodegenerative disorders","volume":"132","author":"Singh","year":"2018","journal-title":"Pharmacol. Res"},{"key":"10.1074\/jbc.RA119.010524_bib86","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1006990925122","article-title":"Metabolism and excretion of mood stabilizers and new anticonvulsants","volume":"19","author":"Ketter","year":"1999","journal-title":"Cell. Mol. Neurobiol"},{"key":"10.1074\/jbc.RA119.010524_bib87","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40263-019-00642-2","article-title":"Long-term neuropsychological outcomes from an open-label phase I\/IIa trial of 2-hydroxypropyl-\u03b2-cyclodextrins (VTS-270) in Niemann-Pick disease, type C1","volume":"33","author":"Farmer","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1074\/jbc.RA119.010524_bib88","doi-asserted-by":"crossref","first-page":"85428","DOI":"10.18632\/oncotarget.19976","article-title":"Generation of patient specific human neural stem cells from Niemann-Pick disease type C patient-derived fibroblasts","volume":"8","author":"Sung","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.RA119.010524_bib89","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2007.06.116","article-title":"Defective cholesterol traffic and neuronal differentiation in neural stem cells of Niemann-Pick type C disease improved by valproic acid, a histone deacetylase inhibitor","volume":"360","author":"Kim","year":"2007","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.RA119.010524_bib90","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/j.1552-4604.1994.tb02036.x","article-title":"Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation","volume":"34","author":"Hussein","year":"1994","journal-title":"J. Clin. Pharmacol"},{"key":"10.1074\/jbc.RA119.010524_bib91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-7258(93)90056-J","article-title":"Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum","volume":"57","author":"Slater","year":"1993","journal-title":"Pharmacol. Ther"},{"key":"10.1074\/jbc.RA119.010524_bib92","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1093\/hmg\/ddt216","article-title":"The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations","volume":"22","author":"Dunmore","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA119.010524_bib93","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s13311-013-0217-2","article-title":"Treatment of Niemann-Pick type C disease by histone deacetylase inhibitors","volume":"10","author":"Helquist","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1074\/jbc.RA119.010524_bib94","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1194\/jlr.M500388-JLR200","article-title":"Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells","volume":"47","author":"Pipalia","year":"2006","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA119.010524_bib95","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1038\/s41467-018-06115-2","article-title":"Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD","volume":"9","author":"Schultz","year":"2018","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA119.010524_bib96","doi-asserted-by":"crossref","first-page":"24367","DOI":"10.1074\/jbc.M002184200","volume":"275","author":"Davies","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib97","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexcr.2012.10.004","article-title":"The histone deacetylase inhibitor trichostatin A reduces lysosomal pH and enhances cisplatin-induced apoptosis","volume":"319","author":"Eriksson","year":"2013","journal-title":"Exp. Cell Res"},{"key":"10.1074\/jbc.RA119.010524_bib98","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2012.10.025","article-title":"Histone acetylation regulates intracellular pH","volume":"49","author":"McBrian","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA119.010524_bib99","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.1987.36.213","article-title":"The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH","volume":"36","author":"Krogstad","year":"1987","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"10.1074\/jbc.RA119.010524_bib100","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1126\/science.290.5500.2295","article-title":"Transmembrane molecular pump activity of Niemann-Pick C1 protein","volume":"290","author":"Davies","year":"2000","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.010524_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-62703-336-7_3","article-title":"A simple method to visualize and assess the integrity of lysosomal membrane in mammalian cells using a fluorescent dye","volume":"991","author":"Sohaebuddin","year":"2013","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/jbc.RA119.010524_bib102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cmet.2009.05.009","article-title":"Identification of cholesterol-regulating genes by targeted RNAi screening","volume":"10","author":"Bartz","year":"2009","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.RA119.010524_bib103","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/dbio.1996.0263","article-title":"Structural change of the endoplasmic reticulum during fertilization: evidence for loss of membrane continuity using the green fluorescent protein","volume":"179","author":"Terasaki","year":"1996","journal-title":"Dev. Biol"},{"key":"10.1074\/jbc.RA119.010524_bib104","doi-asserted-by":"crossref","first-page":"16781","DOI":"10.1074\/jbc.M111.332031","article-title":"Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC)","volume":"287","author":"Qadri","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib105","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/j.1600-0854.2008.00806.x","article-title":"Chemical and biological folding contribute to temperature-sensitive \u0394F508 CFTR trafficking","volume":"9","author":"Wang","year":"2008","journal-title":"Traffic"},{"key":"10.1074\/jbc.RA119.010524_bib106","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.200401035","article-title":"COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code","volume":"167","author":"Wang","year":"2004","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.RA119.010524_bib107","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","article-title":"Genetic variations and treatments that affect the lifespan of the NPC1 mouse","volume":"49","author":"Liu","year":"2008","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA119.010524_bib108","doi-asserted-by":"crossref","first-page":"18851","DOI":"10.1074\/jbc.M312795200","article-title":"Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis","volume":"279","author":"Lagace","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib109","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1074\/jbc.M109.057836","article-title":"Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the Alzheimer amyloid precursor protein","volume":"285","author":"Venkataramani","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib110","doi-asserted-by":"crossref","first-page":"27586","DOI":"10.1074\/jbc.M303740200","article-title":"Valproate induces replication-independent active DNA demethylation","volume":"278","author":"Detich","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib111","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.RA119.010524_bib112","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.RA119.010524_bib113","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1471-4159.1985.tb08793.x","article-title":"Blood-brain barrier transport of valproic acid","volume":"44","author":"Cornford","year":"1985","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA119.010524_bib114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/mvre.2001.2378","article-title":"In vivo evidence for brain-to-blood efflux transport of valproic acid across the blood-brain barrier","volume":"63","author":"Kakee","year":"2002","journal-title":"Microvasc. Res"},{"key":"10.1074\/jbc.RA119.010524_bib115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","article-title":"Valproic acid alleviates memory deficits and attenuates amyloid-beta deposition in transgenic mouse model of Alzheimer's disease","volume":"51","author":"Xuan","year":"2015","journal-title":"Mol. Neurobiol"},{"key":"10.1074\/jbc.RA119.010524_bib116","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","article-title":"Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"155","author":"Feng","year":"2008","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.RA119.010524_bib117","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1074\/jbc.M108861200","article-title":"Vesicular and non-vesicular sterol transport in living cells: the endocytic recycling compartment is a major sterol storage organelle","volume":"277","author":"Hao","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib118","doi-asserted-by":"crossref","first-page":"e106224","DOI":"10.1371\/journal.pone.0106224","article-title":"The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition","volume":"9","author":"Hutt","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010524_bib119","doi-asserted-by":"crossref","first-page":"e1001998","DOI":"10.1371\/journal.pbio.1001998","article-title":"Modulation of the maladaptive stress response to manage diseases of protein folding","volume":"12","author":"Roth","year":"2014","journal-title":"PLoS Biol"},{"key":"10.1074\/jbc.RA119.010524_bib120","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Commentary: lysosomotropic agents","volume":"23","author":"de Duve","year":"1974","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.RA119.010524_bib121","doi-asserted-by":"crossref","first-page":"e0173771","DOI":"10.1371\/journal.pone.0173771","article-title":"Lysosomal adaptation: how cells respond to lysosomotropic compounds","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010524_bib122","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.51.5.786","article-title":"Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis","volume":"51","author":"Allfrey","year":"1964","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.010524_bib123","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.molcel.2006.06.026","article-title":"Substrate and functional diversity of lysine acetylation revealed by a proteomics survey","volume":"23","author":"Kim","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA119.010524_bib124","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA119.010524_bib125","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrm3841","article-title":"The growing landscape of lysine acetylation links metabolism and cell signalling","volume":"15","author":"Choudhary","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.RA119.010524_bib126","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2009.06385.x","article-title":"Valproic acid induces functional heat-shock protein 70 via class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation","volume":"111","author":"Marinova","year":"2009","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA119.010524_bib127","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2010.04.013","article-title":"Potent neuroprotective effects of novel structural derivatives of valproic acid: potential roles of HDAC inhibition and HSP70 induction","volume":"476","author":"Leng","year":"2010","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.RA119.010524_bib128","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1523\/JNEUROSCI.4173-14.2015","article-title":"A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele","volume":"35","author":"Praggastis","year":"2015","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA119.010524_bib129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/1471-2164-9-507","article-title":"Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism","volume":"9","author":"Chittur","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1074\/jbc.RA119.010524_bib130","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1074\/jbc.M116.770578","article-title":"Normalization of hepatic homeostasis in the Npc1(nmf164) mouse model of Niemann-Pick type C disease treated with the histone deacetylase inhibitor Vorinostat","volume":"292","author":"Munkacsi","year":"2017","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib131","doi-asserted-by":"crossref","first-page":"e53394","DOI":"10.1371\/journal.pone.0053394","article-title":"Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux","volume":"8","author":"Nunes","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010524_bib132","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1194\/jlr.M028241","article-title":"Cyclodextrin mediates rapid changes in lipid balance in Npc1\u2212\/\u2212 mice without carrying cholesterol through the bloodstream","volume":"53","author":"Taylor","year":"2012","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA119.010524_bib133","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0920-1211(91)90028-E","article-title":"Comparison of valproate concentrations in human plasma, CSF and brain tissue after administration of different formulations of valproate or valpromide","volume":"9","author":"Wieser","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1074\/jbc.RA119.010524_bib134","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.31.4_Part_2.486","article-title":"Human brain, plasma, and cerebrospinal fluid concentration of sodium valproate after 72 hours of therapy","volume":"31","author":"Vajda","year":"1981","journal-title":"Neurology"},{"key":"10.1074\/jbc.RA119.010524_bib135","doi-asserted-by":"crossref","first-page":"28581","DOI":"10.1074\/jbc.M414024200","article-title":"The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol","volume":"280","author":"Millard","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010524_bib136","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1194\/jlr.P013524","article-title":"Niemann-Pick type C disease: characterizing lipid levels in patients with variant lysosomal cholesterol storage","volume":"52","author":"T\u00e4ngemo","year":"2011","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA119.010524_bib137","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1\u20132 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817494403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817494403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.010524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T11:17:03Z","timestamp":1640949423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925817494403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":137,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0021925817494403"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.010524","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/724187","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.010524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Subramanian et al.","name":"copyright","label":"Copyright"}]}}